Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
"RNA, 5S ribosomal pseudogene 302" (RNA5SP302) refers to a pseudogene derived from the 5S ribosomal RNA gene family. 5S ribosomal RNA (5S rRNA) is a fundamental RNA component of the large ribosomal subunit, essential for ribosome structure and function, but in this context, the "pseudogene" indicates that RNA5SP302 is a non-functional copy, not transcribed into functional 5S rRNA and not involved in protein synthesis[1][3][4]. Ribosomal RNA pseudogenes are typically considered genomic "fossils"—they lack protein-coding potential, do not produce functional products, and are not recognized as drug targets, receptors, or therapeutically actionable biomolecules[4][6]. Pseudogenes may sometimes participate in regulatory functions such as acting as competitive endogenous RNAs, but there is no evidence or literature describing RNA5SP302 as having such functions, nor as being associated with any human disease or therapeutic intervention[4][6]. **Key points:** - This gene is a **pseudogene**, not a functional ribosomal RNA gene[4]. - Pseudogenes are classified as "other non-coding RNA," not as enzymes, receptors, or protein-coding targets[4][6]. - There is no evidence it is a **therapeutic target**, or that any drugs act on or via this pseudogene. - No notable disease or biomarker associations for this specific pseudogene have been reported. The designation "5S ribosomal RNA pseudogene 302" means it is one of potentially many identified non-functional copies of the 5S rRNA gene; it should *not* be conflated with the functional 5S rRNA molecule or its gene locus, which is universally essential for ribosome activity and cell viability[1][3][5]. **Correction:** This target is **incorrect** for drug discovery or therapeutic target purposes, as it is a non-coding, non-functional pseudogene rather than an active biomolecule.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on 5S ribosomal RNA pseudogene 302 (RNA5SP302).